Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
oxidative stress3585 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28146 | 16265100 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A28154 | 16252194 | Turk J Gastroenterol | Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. | 2005 | Details |
| A28168 | 16231589 | Eur Rev Med Pharmacol Sci | The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. | 2006 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28174 | 16225478 | Aliment Pharmacol Ther | Review article: role of oxidative stress in the progression of non-alcoholic steatosis. | 2005 | Details |
| A28178 | 16225472 | Aliment Pharmacol Ther | Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. | 2005 | Details |
| A28183 | 16212005 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management]. | 2005 | Details |
| A28184 | 16212004 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. | 2005 | Details |
| A28192 | 16198621 | Hepatol Res | Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. | 2005 | Details |
| A28201 | 16162151 | Liver Int | Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. | 2005 | Details |
| A28216 | 16108837 | Diabet Med | Recent concepts in non-alcoholic fatty liver disease. | 2005 | Details |
| A28218 | 16101243 | Nihon Rinsho | [Tumor suppressor gene PTEN and non-alcoholic steatohepatitis (NASH)]. | 2005 | Details |
| A28234 | 16003131 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and insulin resistance. | 2005 | Details |
| A28247 | 15970480 | Front Biosci | Uncoupling protein-2 and non-alcoholic fatty liver disease. | 2005 | Details |
| A28251 | 15951547 | Gut | Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. | 2005 | Details |
| A28254 | 15946429 | Obes Surg | Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings. | 2005 | Details |
| A28256 | 15942443 | J Clin Gastroenterol | Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. | 2005 | Details |
| A28268 | 15887119 | Gastroenterology | Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. | 2005 | Details |
| A28272 | 15859390 | Ann Ital Med Int | [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?]. | 2005 | Details |
| A28287 | 15784031 | Am J Gastroenterol | Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. | 2005 | Details |
| A28293 | 15763346 | J Hepatol | Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. | 2005 | Details |
| A28296 | 15759791 | Rev Gastroenterol Mex | [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis]. | 2005 | Details |
| A28308 | 15723740 | Nutrition | Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. | 2005 | Details |
| A28310 | 15716798 | Curr Opin Clin Nutr Metab Care | Fatty liver in the intensive care unit. | 2005 | Details |
| A28311 | 15712657 | Dig Dis Sci | Nonalcoholic fatty liver disease: a clinical review. | 2005 | Details |
| A28313 | 15709919 | Expert Opin Investig Drugs | Recent advances in the treatment of non-alcoholic fatty liver disease. | 2005 | Details |
| A28314 | 15708540 | Clin Biochem | Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. | 2005 | Details |
| A28325 | 15670668 | Alcohol | Mechanisms of non-alcoholic steatohepatitis. | 2004 | Details |
| A28332 | 15625647 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease: a review of current understanding and future impact. | 2004 | Details |
| A28338 | 15603755 | Mutat Res | Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. | 2005 | Details |
| A28346 | 15561641 | Best Pract Res Clin Gastroenterol | Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. | 2004 | Details |
| A28348 | 15554233 | Drug Metab Rev | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 2004 | Details |
| A28351 | 15522905 | FASEB J | A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. | 2004 | Details |
| A28357 | 15505593 | Ann Hepatol | Nonalcoholic fatty liver disease. | 2005 | Details |
| A28366 | 15454290 | Free Radic Biol Med | Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. | 2004 | Details |
| A28378 | 15331069 | Clin Liver Dis | The potential role of genes in nonalcoholic fatty liver disease. | 2004 | Details |
| A28381 | 15331063 | Clin Liver Dis | Nonalcoholic fatty liver disease in the pediatric population. | 2004 | Details |
| A28412 | 15119115 | Orv Hetil | [Role of lipid peroxidation in non-alcoholic steatohepatitis]. | 2004 | Details |
| A28438 | 14762795 | Gastroenterology | Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. | 2004 | Details |
| A28441 | 14734144 | Hepatol Res | CYP2E1: from ASH to NASH. | 2004 | Details |
| A28442 | 14720121 | Clin Sci (Lond) | Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. | 2004 | Details |
| A28443 | 14708419 | J Int Med Res | A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). | 2004 | Details |
| A28446 | 14685853 | Virchows Arch | Non-alcoholic fatty liver disease: an emerging pathological spectrum. | 2003 | Details |
| A28453 | 14613504 | Nutr J | Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. | 2003 | Details |
| A28455 | 14609346 | Drugs | Advances in the understanding and treatment of nonalcoholic fatty liver disease. | 2003 | Details |
| A28456 | 14604432 | Clin Sci (Lond) | Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? | 2004 | Details |
| A28460 | 14582465 | Acta Med Croatica | [Non-alcoholic steatohepatitis]. | 2003 | Details |
| A28464 | 14556645 | Clin Sci (Lond) | Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. | 2004 | Details |
| A28470 | 12971963 | J Hepatol | Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. | 2003 | Details |
| A28472 | 12908728 | Eur Rev Med Pharmacol Sci | Experimental observations and clinical implications of fasting and diet supplementation in fatty livers. | 2003 | Details |
| A28496 | 12530944 | Curr Gastroenterol Rep | Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. | 2003 | Details |
| A28497 | 12516196 | Clin Liver Dis | The liver in obesity and type 2 diabetes mellitus. | 2002 | Details |
| A28502 | 12468416 | Best Pract Res Clin Endocrinol Metab | Obesity and liver disease. | 2002 | Details |
| A28512 | 12406441 | Best Pract Res Clin Gastroenterol | The metabolic abnormalities associated with non-alcoholic fatty liver disease. | 2002 | Details |
| A28514 | 12406439 | Best Pract Res Clin Gastroenterol | Animal models of steatohepatitis. | 2002 | Details |
| A28515 | 12406438 | Best Pract Res Clin Gastroenterol | Pathogenesis of steatohepatitis. | 2002 | Details |
| A28519 | 12296456 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. | 2002 | Details |
| A28520 | 12214335 | Rev Gastroenterol Mex | [Non-alcoholic steatohepatitis]. | 2002 | Details |
| A28525 | 12122975 | Rev Gastroenterol Disord | Nonalcoholic fatty liver disease. | 2002 | Details |
| A28528 | 12076862 | J Hepatol | In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. | 2002 | Details |
| A28530 | 12000605 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease. | 2002 | Details |
| A28532 | 11944631 | Semin Gastrointest Dis | Fat and the liver--a molecular overview. | 2002 | Details |
| A28542 | 11756758 | Adv Anat Pathol | The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. | 2002 | Details |
| A28544 | 11690701 | J Hepatol | Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. | 2001 | Details |
| A28546 | 11603045 | Tidsskr Nor Laegeforen | [Non-alcoholic steatohepatitis]. | 2001 | Details |
| A28548 | 11584365 | Hepatology | Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. | 2001 | Details |
| A28645 | 35192632 | PLoS One | Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model. | 2022 | Details |
| A28711 | 35105958 | Acta Pharmacol Sin | Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH. | 2022 | Details |
| A28759 | 35052810 | Biomedicines | Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A28782 | 35008926 | Int J Mol Sci | Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand? | 2022 | Details |
| A28842 | 34919247 | Eur Rev Med Pharmacol Sci | A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients. | 2021 | Details |
| A28894 | 34856227 | J Control Release | Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. | 2021 | Details |
| A28906 | 34843960 | Pharmacol Res | Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases. | 2021 | Details |
| A28945 | 34789265 | J Nanobiotechnology | Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis. | 2021 | Details |
| A28956 | 34781165 | Redox Biol | The sex steroid precursor dehydroepiandrosterone prevents nonalcoholic steatohepatitis by activating the AMPK pathway mediated by GPR30. | 2021 | Details |
| A28972 | 34760013 | Res Pharm Sci | Attenuating effects of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis: role of SIRT1/Nrf2 pathway. | 2021 | Details |
| A29007 | 34712137 | Front Pharmacol | Micronized Palmitoylethanolamide Ameliorates Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis via Inhibiting Inflammation and Restoring Autophagy. | 2021 | Details |
| A29027 | 34679736 | Antioxidants (Basel) | Oxidative Stress Linked Organ Lipid Hydroperoxidation and Dysregulation in Mouse Model of Nonalcoholic Steatohepatitis: Revealed by Lipidomic Profiling of Liver and Kidney. | 2021 | Details |
| A29150 | 34503544 | Nutr Metab (Lond) | Dihydromyricetin attenuates palmitic acid-induced oxidative stress by promoting autophagy via SIRT3-ATG4B signaling in hepatocytes. | 2021 | Details |
| A29183 | 34441565 | Foods | White Button Mushroom Extracts Modulate Hepatic Fibrosis Progression, Inflammation, and Oxidative Stress In Vitro and in LDLR-/- Mice. | 2021 | Details |
| A29294 | 34289365 | Cell Rep | Modeling alcohol-associated liver disease in a human Liver-Chip. | 2021 | Details |
| A29303 | 34278710 | Aging Cell | Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice. | 2021 | Details |
| A29623 | 33787460 | J Recept Signal Transduct Res | SIRT1/NFκB pathway mediates anti-inflammatory and anti-apoptotic effects of rosmarinic acid on in a mouse model of nonalcoholic steatohepatitis (NASH). | 2021 | Details |
| A29659 | 33729641 | J Biochem Mol Toxicol | Differentially expressed proteins obtained by label-free quantitative proteomic analysis reveal affected biological processes and functions in Western diet-induced steatohepatitis. | 2021 | Details |
| A29858 | 33383845 | Antioxidants (Basel) | Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH). | 2020 | Details |
| A29876 | 33354276 | Oxid Med Cell Longev | Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. | 2020 | Details |
| A30119 | 32954509 | Ann N Y Acad Sci | Characterization of hydrogen sulfide toxicity to human corneal stromal fibroblasts. | 2020 | Details |
| A30164 | 32875622 | J Food Biochem | Effect of cassava flour on the lipidic and redox profile of Wistar rats with dyslipidemia. | 2020 | Details |
| A30204 | 32821335 | World J Hepatol | Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. | 2020 | Details |
| A30438 | 32443737 | Cancers (Basel) | Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma. | 2020 | Details |
| A30564 | 32205234 | Pharmacol Res | Obesity and NRF2-mediated cytoprotection: Where is the missing link? | 2020 | Details |
| A30624 | 32093102 | Int J Mol Sci | Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress. | 2020 | Details |
| A30665 | 32025605 | Hepatol Commun | Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice. | 2019 | Details |
| A30713 | 31921324 | Nutr Metab (Lond) | High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats. | 2020 | Details |
| A30790 | 31777145 | Int J Exp Pathol | The effects of intravitreal H2 S application on apoptosis in the retina and cornea in experimental glaucoma model. | 2019 | Details |
| A30854 | 31667206 | Regen Ther | Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions. | 2019 | Details |
| A30956 | 31479766 | Nitric Oxide | Hydrogen sulfide potentiates the favorable metabolic effects of inorganic nitrite in type 2 diabetic rats. | 2019 | Details |
| A31019 | 31388629 | Hepatol Commun | Tropifexor-Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents. | 2019 | Details |
| A31047 | 31321239 | Biomed Res Int | Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice. | 2019 | Details |
| A31130 | 31193082 | Heliyon | Development of a mouse iron overload-induced liver injury model and evaluation of the beneficial effects of placenta extract on iron metabolism. | 2019 | Details |